EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides

Crawford Currie, Christian Bjerknes, Bomi Framroze iD

Marine Drugs · 30.10.2024 · 22 (11) · 490

DOI: 10.3390/md22110490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 30.10.2024. Verfasst von Crawford Currie und 2 weiteren Autor:innen. Beteiligte Einrichtung: HBC Immunology Inc., Menlo Park, CA 2043, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor, Islets of Langerhans, Receptors, Gastrointestinal Hormone, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HBC Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines the in vitro effects of a soluble protein hydrolysate (SPH) derived from Atlantic salmon (Salmo salar) on incretin receptor activity and pancreatic islet cell protection to explore the mechanisms underlying SPH’s observed benefits on weight loss and metabolic health in overweight individuals. SPH demonstrated a dose-dependent enhancement of glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor activity, with significant increases of 2.4-fold (p < 0.05) and 2.6-fold (p < 0.01) at 10 mg/mL, respectively, compared to the control. Pancreatic islet cell assays showed a substantial proliferation effect, with up to a 57% increase at 50 µL/well, indicating potential protective properties against inflammation-induced cell loss. Notably, the smallest SPH peptide fraction (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 ReceptorIslets of LangerhansReceptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 Receptor AgonistsAnimalsSalmo salarGlucagon-Like Peptide 1Protein HydrolysatesCell ProliferationHumansPeptidesGlucagon-Like PeptidesSemaglutide

Stichwörter der Autor:innen

ALOX12GIP receptorGLP-1 receptorbioactive peptideshealthy ageingmetabolic healthpancreatic islet cellssalmon protein hydrolysatesoluble protein hydrolysateweight management

Substanzen

Glucagon-Like Peptide-1 ReceptorReceptors, Gastrointestinal HormoneGlucagon-Like Peptide 1Protein HydrolysatesPeptidesGlucagon-Like PeptidesGlucagon-Like Peptide-1 Receptor AgonistsSemaglutidegastric inhibitory polypeptide receptor

Autor:innen und Institutionen

  • HBC Immunology Inc., Menlo Park, CA 2043, USA.
  • Hofseth BioCare, 6003 Ålesund, Norway.

ORCID-Profile: Bomi Framroze

Förderung

  • HBC Immunology

Zitieren

APA

Currie, C., Bjerknes, C., & Framroze, B. (2024). Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides. Marine Drugs, 22(11), 490. https://doi.org/10.3390/md22110490

Vancouver

Currie C, Bjerknes C, Framroze B. Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides. Marine Drugs. 2024;22(11):490. doi:10.3390/md22110490

BibTeX
@article{Currie2024,
  author = {Currie, Crawford and Bjerknes, Christian and Framroze, Bomi},
  title = {Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides},
  journal = {Marine Drugs},
  year = {2024},
  volume = {22},
  number = {11},
  pages = {490},
  doi = {10.3390/md22110490}
}
Kostenlos starten →